Addressing tuberculosis – a global health emergency – through scalable RNA vaccine technology developed in NSW

10+ million new tuberculosis cases and 1.3 million deaths every year

Significant impact across our region

Multiple tuberculosis antigens

Active and latent disease coverage

Scalable mRNA platform

Our Lead Program: Multiplexed mRNA Tuberculosis Vaccine